ST. PAUL, Minn.--(BUSINESS WIRE)--Dec. 13, 2011--
Cardiovascular Systems, Inc. (CSI; Nasdaq: CSII), Stealth 360°™ PAD
System has been honored as a New Technology of the Year by LifeScience
Alley. The annual award is given to the top 10 novel products that
address a medical need, demonstrate the ability to improve healthcare
and have significant market potential. Expert industry judges selected
ground-breaking medical and health care technologies from established
and emerging organizations from around the U.S. and Canada. Companies
presented their technologies at New Technology Showcase of the
LifeScience Alley Conference & Expo in Minneapolis, which drew
approximately 1,500 professionals from more than 12 countries and 30
states.
“We thank LifeScience Alley for this recognition — a direct reflection
of the hard work and many contributions of our talented employees in
Minnesota,” said
David L. Martin
, CSI president and chief executive
officer. “This honor recognizes CSI’s innovative technology to safely
treat routine and complex peripheral arterial disease (PAD) cases. The
Stealth 360° removes harmful plaque from arteries in a very short
treatment time in the hospital or physician’s office. Our technologies,
combined with our growing wealth of clinical data, are helping
physicians achieve a new standard of care for PAD patients to save limbs
and lives.”
The Stealth 360° utilizes CSI’s proven orbital mechanism of action,
which protects healthy tissue while removing difficult-to-treat plaque
in patients with peripheral arterial disease. The Stealth 360°
eliminates the large capital equipment portion of its predecessor
product for a more compact and easier-to-use system. With simple,
convenient speed adjustments on the handle, physicians can vary the
speed of orbit and have greater control to achieve shorter procedure
times and a high percentage of plaque reduction. The device also reduces
set-up and staff time.
About LifeScience Alley
LifeScience Alley is an international leader in sharing best practices,
and is the largest state-based life sciences trade association in the
United States. With a 26-year track record of providing valuable
services and results-oriented outcomes to its members, LifeScience Alley
enables business success through educating workforces, influencing state
and federal public policy, supporting advancement in research and
technological innovation, and fostering industry connections. The
Association’s membership employs approximately 250,000 Minnesotans and
its reach extends throughout the Midwest and Canada. For additional
information, visit: www.LifeScienceAlley.org.
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical
device company focused on developing and commercializing innovative
solutions for treating vascular and coronary disease. The company's
Stealth 360°TM, Diamondback 360® and Predator 360®
PAD Systems treat calcified and fibrotic plaque in arterial vessels
throughout the leg in a few minutes of treatment time, and address many
of the limitations associated with existing surgical, catheter and
pharmacological treatment alternatives. The U.S. FDA granted 510(k)
clearance for the use of the Diamondback 360° in August 2007, the
Predator 360° in March 2009 and for the Stealth 360° in March 2011. To
date, more than 55,000 PAD procedures have been performed using CSI's
PAD systems in leading institutions across the United States.
CSI has also commenced its ORBIT II Investigational Device Exemption
clinical trial to evaluate the safety and effectiveness of its orbital
technology in treating coronary arteries. The coronary system is limited
by federal law to investigational use and is currently not commercially
available in the United States.
For more information, visit the company’s website at www.csi360.com.
Source: Cardiovascular Systems, Inc.
For Cardiovascular Systems, Inc.
Investor Relations,
651-259-2800
investorrelations@csi360.com
or
Padilla
Speer Beardsley
Marian Briggs, 612-455-1742
mbriggs@psbpr.com
Nancy
A. Johnson, 612-455-1745
njohnson@psbpr.com